Bio-Rad Laboratories, Inc. Stock NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.00 USD | +8.93% |
|
+8.93% | +8.46% |
| Market Cap | 9.35B 8.08B 7.55B 6.93B 13.03B 889B 13.23B 88.58B 34.77B 446B 35.1B 34.33B 1,474B | P/E 2026 * |
42.3x | P/E 2027 * | 41.4x |
|---|---|---|---|---|---|
| Enterprise Value | 8.6B 7.44B 6.94B 6.37B 11.98B 818B 12.17B 81.48B 31.98B 410B 32.28B 31.58B 1,356B | EV / Sales 2026 * |
3.34x | EV / Sales 2027 * | 3.18x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.93% | ||
| 1 week | +8.93% | ||
| Current month | +8.93% | ||
| 1 month | +14.87% | ||
| 3 months | +31.88% | ||
| 6 months | +14.22% | ||
| Current year | +8.46% |
| 1 month | 309.37 |  | 337 |
| Current year | 244.54 | | 337 |
| 1 year | 244.54 | | 337 |
| 3 years | 0 | | 373.78 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.93% | +8.93% | - | - | 9.35B | |
| -0.14% | +2.00% | -19.71% | +2.38% | 187B | |
| +1.44% | +2.07% | -6.16% | +5.09% | 112B | |
| -1.40% | +2.93% | +12.39% | +72.56% | 61.15B | |
| +2.38% | +3.92% | +32.78% | +60.21% | 54.39B | |
| -0.12% | +6.79% | -8.60% | -37.18% | 48.17B | |
| +2.08% | +1.56% | +7.47% | -23.62% | 31.98B | |
| +2.09% | -10.31% | - | - | 30.91B | |
| +1.57% | +3.85% | +46.93% | -11.52% | 24.92B | |
| +2.45% | +3.97% | -2.22% | +4.63% | 23.15B | |
| Average | +1.52% | +1.86% | +7.86% | +9.07% | 63.64B | |
| Weighted average by Cap. | +0.42% | +2.17% | -1.63% | +11.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.23B 2.08B 1.91B 3.59B 245B 3.64B 24.39B 9.57B 123B 9.66B 9.45B 406B | 2.63B 2.28B 2.13B 1.95B 3.67B 251B 3.73B 24.96B 9.8B 126B 9.89B 9.67B 415B |
| Net income | 225M 195M 182M 167M 314M 21.41B 319M 2.13B 837M 10.73B 845M 826M 35.48B | 230M 199M 186M 170M 321M 21.89B 326M 2.18B 856M 10.97B 864M 845M 36.27B |
| Net Debt | -749M -648M -605M -555M -1.04B -71.29B -1.06B -7.1B -2.79B -35.73B -2.81B -2.75B -118B | -965M -835M -780M -715M -1.35B -91.88B -1.37B -9.15B -3.59B -46.05B -3.63B -3.55B -152B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
